Alferon

Alferon

A purified human interferon (IFN), IFN-alfa-n3, which has been used to treat various cancers (leukaemia, melanoma, Kaposi’s sarcoma) and viral infections, including genital warts, hepatitis B and hepatitis C.

Adverse effects
Injection site reactions, diarrhoea, upset stomach, loss of appetite, dry mouth, nausea, flu-like symptoms, vomiting, and occasionally hair loss.
References in periodicals archive ?
Our plan is to develop both Ampligen and Alferon and bring them to the market place.
Like monoclonal antibodies, non-specific immunotherapies or cytokine therapy such as interferons - interferon alpha (Roferon-A [2a], Intron A [2b], Alferon [2a]) and interleukins - interleukin-2, IL-2, or aldesleukin (Proleukin) also help the immune system destroy cancer cells.
Designation for Alferon N Injection, also known as interferon alfa-n3, as a potential treatment of MERS.
to seek approval of Alferon N Injection in Australia and New Zealand and to commence distribution of Alferon in both countries on a named-patient basis, where deemed appropriate.
It was reported yesterday that the agreement has been signed for the sales/marketing of Alferon N Injection, its Food and Drug Administration approved natural interferon, in the United States.
Hemispherx Biopharma announced it is seeking South African government approval to study Alferon N, the only FDA-approved natural interferon, to see if it can suppress HIV replication and eliminate latent HIV, A study released by the Wistar Institute at the University of Pennsylvania previously showed that interferon decreases HIV-1 viral levels and controls the virus after antiretroviral therapy is discontinued.
The researcher said that in this study they report that Alferon N can inhibit wild type and Tamiflu-resistant H7N9 virus replication in vitro.
The TLR3 findings provide a therapeutic rationale for studies of interferon alpha-n3 (Alferon).
Medications being developed to prevent infections caused by viral bioweapons and other diseases include 1) Oral IFN-[alpha] or Alferon low dose oral (LDO) (Hemispherx Biopharma, Inc., Philadelphia, PA, USA); 2) inhalable IFN-[gamma] (InterMune, Brisbane, CA, USA); 3) dsRNA [Poly (ICLC)] or Ampligen (Hemispherx Biopharma, Inc.); 4) ssRNA (Aldara and Resiquimod from 3M Pharmaceuticals, St.
The interferon alfa agents include interferon alfa-2a (Roferon-A), peginterferon alfa-2a (Pegasys), interferon alfa-2b (Intron A), peginterferon alfa-2b (Peg-Intron), interferon alfacon-1 (Infergen), and interferon alfa-n3 (Alferon N).
M2 PHARMA-August 18, 2015-Hemispherx Biopharma extends US strategic agreement with Armada Health Care for Alferon N Injection
M2 EQUITYBITES-August 18, 2015-Hemispherx Biopharma extends US strategic agreement with Armada Health Care for Alferon N Injection